Lexeo Therapeutics CMO Offloads $98K in Shares Ahead of Pivotal Trial Data
Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Chief Medical Officer Narinder Pal Bhalla executed a sale of 22,306 shares on July 1, 2026, totaling $98,592. The transaction, conducted at a weighted average price of $4.42 per share, was specifically designated to satisfy tax liabilities associated with the vesting of performance Restricted Stock Units (RSUs…